Benzinga
Benzinga
Benzinga
domingo, septiembre 20

Aethlon Medical Inc

AEMDNASDAQ
Trade with Public
Trade with Public
$6.31
-0.47-6.93%
al cierre: Sep 18, 5:00 PM EST
$6.48
0.172.69%
After hour: Sep 18, 7:59 PM EST
Fusiones y adquisiciones: North Immunology, Inc. ("North Immunology"), Nighthawk Merger Sub Corp., a wholly owned subsidiary of Aethlon, and Nighthawk Second Merger Sub, LLC, a wholly owned subsidiary of Aethlon. announced it will be merged with Aethlon Medical (AEMD) on Thursday, September 17, 2026 for $346.5M paid in stock
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadCompararInforme de acciones

Aethlon Medical Analyst Price Targets

Wall Street analyst price targets and consensus rating for Aethlon Medical (AEMD).

Price Target Range — 6 Quarters

Analyst Consensus — 1 Analysts

1Hold
Consensus RatingBuy# Analysts1Avg. Consensus PT$1438Upside to Avg. PT+22083.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →
DateFirmAnalystActionRating ChangePrice Target
Aug 14, 2025HC Wainwright & Co.Swayampakula RamakanthMaintainedNeutral$2
Jul 7, 2025HC Wainwright & Co.Swayampakula RamakanthAssumesNeutral$2
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Neutral on Aethlon Medical, Maintains $1.5 Price Target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Aethlon Medical (NASDAQ:AEMD) with a Neutral and maintains $1.5 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Assumes Aethlon Medical at Neutral, Announces Price Target of $1.5

HC Wainwright & Co. analyst Swayampakula Ramakanth assumes Aethlon Medical (NASDAQ:AEMD) with a Neutral rating and announces Price Target of $1.5.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Aethlon Medical, Maintains $7 Price Target

HC Wainwright & Co. analyst Vernon Bernardino reiterates Aethlon Medical (NASDAQ:AEMD) with a Buy and maintains $7 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Aethlon Medical, Maintains $7 Price Target

HC Wainwright & Co. analyst Vernon Bernardino reiterates Aethlon Medical (NASDAQ:AEMD) with a Buy and maintains $7 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Aethlon Medical, Maintains $7 Price Target

HC Wainwright & Co. analyst Vernon Bernardino reiterates Aethlon Medical (NASDAQ:AEMD) with a Buy and maintains $7 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Aethlon Medical, Maintains $7 Price Target

HC Wainwright & Co. analyst Vernon Bernardino reiterates Aethlon Medical (NASDAQ:AEMD) with a Buy and maintains $7 price target.
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Datos de mercado proporcionados por APIs de Benzinga

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved